New Insulin Price Cap Could End Up Saving Payers Money in the Long Run
RxBenefits, a pharmacy benefits optimizer (PBO), analyzes how the new Insulin Price Cap, a result of the Inflation Reduction Act, may save payers money in the long run by...
HR Magazine - Current Issue
